Ear on the Street
Air Canada (AC.A : TSX : $18.00)
New Street coverage
TD Newcrest initiates coverage with a "buy", 12-month target price is $25.00
ACE Aviation Holdings (ACE.A : TSX : $33.60)
New Street coverage
TD Newcrest initiates coverage with a "buy", 12-month target price is $43.00
Alexis Nihon REIT (AN.UN : TSX : $19.00)
Cominar REIT raises the cash component of its offer
RBC Capital Markets maintains "outperform", 12-month target price is raised to $19.00
Angiotech Pharmaceuticals (ANP : TSX : $10.32 | ANPI : NASDAQ : US$8.76)
Intensifying competition
TD Newcrest maintains "hold", 12-month target price is US$10.50
Aurelian Resources (ARU : TSX-V : $28.17)
Uncertainty in Ecuador
Blackmont Capital maintains "buy", 12-month target price is $48.35
Cameco Corp. (CCO : TSX : $44.59)
Cigar Lake remediation in line
Desjardins Securities maintains "hold", 12-month target price is $34.00
RBC Capital Markets maintains "top pick", 12-month target price is $67.00
Comaplex Minerals (CMF : TSX : $3.36)
New Street coverage
BMO Capital Markets initiates coverage with a "outperform", 12-month target price is not given
Coastal Contacts Inc. (COA : TSX : $1.15)
Year-end results are basically positive
Canaccord Adams upgrades to "buy", 12-month target price is raised to $1.50
Corriente Resources (CTQ : TSX : $3.00)
Delays at Mirador project in Ecuador
Canaccord Adams maintains "buy", 12-month target price is cut to $6.95
Desjardins Securities maintains "buy", 12-month target price is cut to $6.55
Raymond James maintains "underperform", 12-month target price is cut to $3.00
Enbridge (ENB : TSX : $38.62)
Progress on pipeline project
Canaccord Adams maintains "hold", 12-month target price is $42.00
Gateway Casinos Income Fund (GCI.UN : TSX : $18.67)
Downgrade on price appreciation
TD Newcrest downgrades to "hold", 12-month target price is $17.00
CGI Group (GIB.A : TSX : $8.46 | GIB : NYSE : US$7.19)
To report Q1 on January 30
Canaccord Adams maintains "hold", 12-month target price is $8.00
RBC Capital Markets maintains "sector perform", 12-month target price is $8.00
Gennum Corp. (GND : TSX : $12.97)
Lower than expected Q4
Blackmont Capital maintains "hold", 12-month target price is $14.00
CIBC World Markets maintains "sector perform", 12-month target price is cut to $14.00
GMP Securities maintains "buy", 12-month target price is $16.00
Liponex (LPX : TSX : $2.01)
Positive Phase I/II results lead to fundamental valuation shift
Haywood Securities maintains "sector perform", 12-month target price is raised to $2.50
Lundin Mining (LUN : TSX : $40.82)
Three-for-one share split
CIBC World Markets maintains "sector outperform", 12-month target price is $50.00
MacDonald Dettwiler & Assoc. (MDA : TSX : $49.46)
U.K. government continues support for HIPs
CIBC World Markets maintains "sector outperform", 12-month target price is $55.00
Methanex Corp. (MX : TSX : $30.26 | MEOH : NASDAQ : US$25.67)
Q4 in line
BMO Capital Markets maintains "market perform", 12-month target price is US$27.00
CIBC World Markets maintains "sector underperform", 12-month target price is US$25.00
Raymond James maintains "underperform", 6-12 month target price is US$21.00
RBC Capital Markets maintains "underperform", 12-month target price is cut to US$20.00
Nexen (NXY : TSX : $72.46 | NYSE : US$61.47)
Energy sector takeover target?
Desjardins Securities reduce to "buy", 12-month target price is $75.00
Raymond James maintains "market perform", 6-12 month target price is $68.00
Petro-Canada (PCA : TSX : $44.65 | PCZ : NYSE : US$37.91)
Reports Q4 results and year-end reserves
BMO Capital Markets maintains "market perform", 12-month target price is $58.00
CIBC World Markets maintains "sector ouperformer", 12-month target price is $57.00
RBC Capital Markets rates "outperform", 12-month target price is $53.00
TD Newcrest maintains "buy", 12-month target price is $55.00
Potash Corp. of Saskatchewan (POT : TSX : $172.17 | NYSE : US$146.00)
Q4 earnings reported
BMO Capital Markets maintains "outperform", 12-month target price is US$150.00
CIBC World Markets maintains "sector perform", 12-month target price is US$142.00
RBC Capital Markets rates "outperform", 12-month target price is US$165.00
Patheon Inc. (PTI : TSX : $5.21)
Competitors consolidating
CIBC World Markets maintains "speculative buy", 12-month target price is $5.00
Pacific & Western Credit (PWC : TSX : $11.80)
Special dividend declared
Blackmont Capital maintains "hold", 12-month target price is $13.00
Rogers Communications (RCI.B : TSX : $38.24)
Dwindling upside
TD Newcrest downgrades to "buy", 12-month target price is $45.00
Research In Motion (RIM : TSX : $146.96)
Daylight savings patch for Blackberry
Credit Suisse maintains "underperform", 12-month target price is US$75.00
Suncor Energy (SU : TSX : $87.92 | NYSE : US$74.70)
Post weak fourth quarter results
BMO Nesbitt Burns maintains a "outperform", target price cut to $100.00
CIBC World Markets maintains a "sector outperform", target price is $100.00
Credit Suisse maintains a "outperform", target price is $110.00
Raymond James maintains a "outperform", 6-12 month target price is $105.00
RBC Capital Markets maintains a "sector perform", target price cut to $88.00
TD Newcrest maintains a "buy", 12-month target price is $100.00
Trican Well Service (TCW : TSX : $18.94)
BJ services posted disappointing Q4 numbers
Canaccord Adams maintains "buy", 12-month target price is $25.00
Toromont Industries (TIH : TSX : $23.36)
Q4 preview
BMO Capital Markets maintains "outperform", 12-month target price is $27.50
Thomson Corporation (TOC : TSX : $49.38 | NYSE : US$41.89)
Reports Q4 results on Feb 8
TD Newcrest maintains "hold", 12-month target price is raised to $50.50
Zarlink Semiconductor (ZL : TSX : $2.46 | NYSE : US$2.10)
Q3 in line but lower Q4 guidance
Blackmont Capital maintains "buy", 12-month target price is $3.60
BMO Capital Markets maintains "market perform", 12-month target price is $2.50
GMP Securities maintains "buy", 12-month target price is cut to $2.90
Raymond James maintains "outperform", 6-12 month target price is cut to US$2.75
RBC Capital Markets maintains "sector perform", 12-month target price is $2.50
